MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells.

MLA

Perrin, Simon, et al. “MEK-SHP2 Inhibition Prevents Tibial Pseudarthrosis Caused by NF1 Loss in Schwann Cells and Skeletal Stem/Progenitor Cells.” Science Translational Medicine, vol. 16, no. 753, June 2024, p. eadj1597. EBSCOhost, https://doi.org/10.1126/scitranslmed.adj1597.

APA

Perrin, S., Protic, S., Bretegnier, V., Laurendeau, I., de Lageneste, O. D., Panara, N., Ruckebusch, O., Luka, M., Masson, C., Maillard, T., Coulpier, F., Pannier, S., Wicart, P., Hadj-Rabia, S., Radomska, K. J., Zarhrate, M., Ménager, M., Vidaud, D., Topilko, P., … Colnot, C. (2024). MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells. Science Translational Medicine, 16(753), eadj1597. https://doi.org/10.1126/scitranslmed.adj1597

Chicago

Perrin, Simon, Sanela Protic, Vincent Bretegnier, Ingrid Laurendeau, Oriane Duchamp de Lageneste, Nicolas Panara, Odile Ruckebusch, et al. 2024. “MEK-SHP2 Inhibition Prevents Tibial Pseudarthrosis Caused by NF1 Loss in Schwann Cells and Skeletal Stem/Progenitor Cells.” Science Translational Medicine 16 (753): eadj1597. doi:10.1126/scitranslmed.adj1597.